Back to Search
Start Over
PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation
- Source :
- Recercat. Dipósit de la Recerca de Catalunya, instname, Genome Biology, Dipòsit Digital de la UB, Universidad de Barcelona
- Publication Year :
- 2013
- Publisher :
- Springer Science and Business Media LLC, 2013.
-
Abstract
- Background: DNA methylation is a key epigenetic mechanism for driving and stabilizing cell-fate decisions. Local deposition and removal of DNA methylation are tightly coupled with transcription factor binding, although the relationship varies with the specific differentiation process. Conversion of monocytes to osteoclasts is a unique terminal differentiation process within the hematopoietic system. This differentiation model is relevant to autoimmune disease and cancer, and there is abundant knowledge on the sets of transcription factors involved. Results: Here we focused on DNA methylation changes during osteoclastogenesis. Hypermethylation and hypomethylation changes took place in several thousand genes, including all relevant osteoclast differentiation and function categories. Hypomethylation occurred in association with changes in 5-hydroxymethylcytosine, a proposed intermediate toward demethylation. Transcription factor binding motif analysis revealed an over-representation of PU.1, NF-κB, and AP-1 (Jun/Fos) binding motifs in genes undergoing DNA methylation changes. Among these, only PU.1 motifs were significantly enriched in both hypermethylated and hypomethylated genes; ChIP-seq data analysis confirmed its association to both gene sets. Moreover, PU.1 interacts with both DNMT3b and TET2, suggesting its participation in driving hypermethylation and hydroxymethylation-mediated hypomethylation. Consistent with this, siRNA-mediated PU.1 knockdown in primary monocytes impaired the acquisition of DNA methylation and expression changes, and reduced the association of TET2 and DNMT3b at PU.1 targets during osteoclast differentiation. Conclusions: The work described here identifies key changes in DNA methylation during monocyte-to-osteoclast differentiation and reveals novel roles for PU.1 in this process. This work was supported by grant SAF2011-29635 from the Spanish Ministry of Science and Innovation, grant CIVP16A1834 from Fundación Ramón Areces and grant 2009SGR184 from AGAUR (Catalan Government). LR is supported by a PFIS predoctoral fellowship
- Subjects :
- Autoimmune diseases
Cellular differentiation
ADN
DNMT3B
Osteoclasts
Biology
DNA-binding protein
Monocytes
Dioxygenases
Epigenesis, Genetic
Proteïnes -- Metabolisme
Cytosine
03 medical and health sciences
Transcripció genètica
0302 clinical medicine
Proto-Oncogene Proteins
Humans
Protein Interaction Domains and Motifs
DNA (Cytosine-5-)-Methyltransferases
RNA, Small Interfering
Càncer
Transcription factor
RNA-Directed DNA Methylation
Gene
Cancer
030304 developmental biology
0303 health sciences
Binding Sites
Malalties autoimmunitàries
Research
NF-kappa B
Cell Differentiation
DNA
Methylation
DNA Methylation
Molecular biology
RNA no missatgers
Cell biology
DNA-Binding Proteins
Transcription Factor AP-1
030220 oncology & carcinogenesis
DNA methylation
5-Methylcytosine
Trans-Activators
CpG Islands
Protein Binding
Subjects
Details
- ISSN :
- 14656906 and 20112963
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Genome Biology
- Accession number :
- edsair.doi.dedup.....f0b3306992805ef5466d2b1a18a1e71e
- Full Text :
- https://doi.org/10.1186/gb-2013-14-9-r99